Last reviewed · How we verify

NCT06828302: iPCIT pilot

Internet-delivered Parent-Child Interaction for Parents of Children 2-7 Years With Disruptive Behaviors

Active, enrolled NA Last updated 8 December 2025
What this trial tests

NA trial testing Internet-delivered Parent-Child Interaction Therapy in Disruptive Behavior in 20 participants. Participants enrolled and being followed up; not accepting new ones.

Timeline
10 March 2025
Primary endpoint
30 September 2025
15 June 2026

Quick facts

Lead sponsorKarolinska Institutet
PhaseNA
StatusActive, enrolled
Study typeINTERVENTIONAL
Allocationna
Designsingle group
Maskingnone
Primary purposetreatment
Enrollment20
Start date10 March 2025
Primary completion30 September 2025
Estimated completion15 June 2026
Sites1 location across Sweden

Drugs / interventions tested

Conditions studied

Sponsor

Karolinska Institutet

Who can join

Adults 2 to 7, any sex, with Disruptive Behavior. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this feasibility study is to evaluate feasibility of Internet-delivered Parent-Child Interaction Therapy for parents of children 2-7 years with disruptive behaviors. The main questions it aims to answer are: 1. Could a brief online version of PCIT (iPCIT) be feasible for reducing disruptive behaviors and internalizing problems in young children, and for improving the quality of parent-child interaction? 2. How is iPCIT experienced by participating parents? Participants will receive a 10-week online intervention of Parent-Child Interaction Therapy and answer questionnaires online weekly.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Disruptive Behavior

Currently open trials in the same condition.

Other Karolinska Institutet trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06828302.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing